肢体与内脏缺血后的住院及机构化护理费用与卒中基准比较:一项基于人群队列研究的长期结果
基于牛津血管研究2002至2012年首次发生急性/危重肢体或内脏缺血(ACLVI)事件的351例患者,随访至2017年1月,分析5年总住院护理费用。ACLVI事件后5年总护理费用均值€35,211(SD 50,500),其中€6,443(18%)来自长期机构化护理;费用因事件类型而异(急性内脏缺血€16,476;急性肢体缺血€24,437;危重肢体缺血€46,281;p<0.001)。ACLVI事件后5年住院护理费用显著高于卒中(€28,768 vs €22,623;p=0.004),但纳入机构化护理长期费用后两者相似(€35,211 vs €35,391;p=0.957)。
要点
- ACLVI事件后5年总护理费用均值€35,211(SD 50,500),其中18%为长期机构化护理费用。
- 危重肢体缺血5年费用€46,281,高于急性肢体缺血€24,437和急性内脏缺血€16,476(p<0.001)。
- ACLVI后5年住院费用显著高于卒中(€28,768 vs €22,623;p=0.004),纳入机构化费用后相似(p=0.957)。
核心结论
- ACLVI事件后长期护理费用相当可观,尤其是危重肢体缺血后。
- ACLVI事件后5年住院护理费用显著高于卒中,但纳入机构化护理费用后两者相似。
研究设计与样本
- 基于人群的发病率研究(牛津血管研究),纳入2002至2012年首次发生ACLVI事件的所有患者,共351例。
- 随访至2017年1月,所有患者均有完整5年随访。
- 采用多变量回归评估5年总住院护理费用的基线与后续预测因素。
- ACLVI事件后总体费用与同一人群同期卒中后费用进行基准比较。
主要发现
- 351例ACLVI患者5年总护理费用均值€35,211(SD 50,500),其中€6,443(18%)来自长期机构化护理。
- 费用因事件类型而异:急性内脏缺血€16,476;急性肢体缺血€24,437;危重肢体缺血€46,281;p<0.001。
- 多变量分析显示,糖尿病患者额外费用€11,804(p=0.014),行膝上截肢患者额外费用€25,692(p<0.001)。
- ACLVI事件后5年住院护理费用显著高于卒中(€28,768 vs €22,623;p=0.004)。
- 纳入机构化护理长期费用后,ACLVI与卒中费用相似(€35,211 vs €35,391;p=0.957)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: There are few published data on the acute care or long-term costs after acute/critical limb or visceral ischaemia (ACLVI) events. Using data from patients with acute events in a population based incidence study (Oxford Vascular Study), the present study aimed to determine the long-term costs after an ACLVI event. METHODS: All patients with first ever incident ACLVI from 2002 to 2012 were included. Analysis was based on follow up until January 2017, with all patients having full 5 year follow up. Multivariate regressions were used to assess baseline and subsequent predictors of total 5 year hospital care costs. Overall costs after an ACLVI event were benchmarked against those after stroke in the same population, during the same period. RESULTS: Among 351 patients with an ACLVI event, mean 5 year total care costs were €35,211 (SD 50,500), of which €6443 (18%) were due to long-term institutionalisation. Costs differed by type of event (acute visceral ischaemia €16,476; acute limb ischaemia €24,437; critical limb ischaemia €46,281; p < 0.001). Results of the multivariate analyses showed that patients with diabetes and those undergoing above knee amputations incurred additional costs of €11,804 (p = 0.014) and €25,692 (p < 0.001), respectively. Five year hospital care costs after an ACLVI event were significantly higher than after stroke (€28,768 vs. €22,623; p = 0.004), but similar after including long-term costs of institutionalisation (€35,211 vs. €35,391; p = 0.957). CONCLUSION: Long-term care costs after an ACLVI event are considerable, especially after critical limb ischaemia. Hospital care costs were significantly higher than for stroke over the long term, and were similar after inclusion of costs of institutionalisation.
引用
- Luengo-Fernandez R, Howard DPJ, Nichol KG, et al. Hospital and Institutionalisation Care Costs after Limb and Visceral Ischaemia Benchmarked Against Stroke: Long-Term Results of a Population Based Cohort Study. Eur J Vasc Endovasc Surg. 2018. PMID: 29653901. doi:10.1016/j.ejvs.2018.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。